These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 21342375)

  • 1. Effectiveness of pharmacy interventions in improving availability of essential medicines at the primary healthcare level.
    Nunan M; Duke T
    Trop Med Int Health; 2011 May; 16(5):647-58. PubMed ID: 21342375
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prices, availability and affordability of essential medicines in rural areas of Hubei Province, China.
    Yang H; Dib HH; Zhu M; Qi G; Zhang X
    Health Policy Plan; 2010 May; 25(3):219-29. PubMed ID: 19955093
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Availability of essential medicines in Ethiopia: an efficiency-equity trade-off?
    Carasso BS; Lagarde M; Tesfaye A; Palmer N
    Trop Med Int Health; 2009 Nov; 14(11):1394-400. PubMed ID: 19754520
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Providing affordable essential medicines to African households: the missing policies and institutions for price containment.
    Tetteh Ek
    Soc Sci Med; 2008 Feb; 66(3):569-81. PubMed ID: 18023953
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Commentary: will generic drug stores improve access to essential medicines for the poor in India?
    Kotwani A
    J Public Health Policy; 2010 Jul; 31(2):178-84. PubMed ID: 20535100
    [No Abstract]   [Full Text] [Related]  

  • 6. Availability and affordability of essential medicines: exploring the health seeking behaviours and health service utilisation for children under-5 years living in squatter settlement of Karachi, Pakistan.
    Shafiq Y; Shaikh BT; Kumar R
    J Ayub Med Coll Abbottabad; 2011; 23(1):132-8. PubMed ID: 22830168
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Drug supplies in primary care units at the Ministry of Health in Mexico].
    Gómez-Dantés O; Garrido-Latorre F; Tirado-Gómez LL; Ramírez D; Macías C
    Salud Publica Mex; 2001; 43(3):224-32. PubMed ID: 11452699
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Twenty-five years of essential medicines.
    Quick JD; Hogerzeil HV; Velasquez G; Rago L
    Bull World Health Organ; 2002; 80(11):913-4. PubMed ID: 12481216
    [No Abstract]   [Full Text] [Related]  

  • 9. TRIPS, pharmaceutical patents, and access to essential medicines: a long way from Seattle to Doha.
    't Hoen E
    Chic J Int Law; 2002; 3(1):27-46. PubMed ID: 15709298
    [No Abstract]   [Full Text] [Related]  

  • 10. Is the pharmaceutical industry improving with regard to access to essential medicines?
    Hogerzeil HV; Iyer JK; Urlings L; Prasad T; Brewer S
    Lancet Glob Health; 2014 Mar; 2(3):e139-40. PubMed ID: 25102843
    [No Abstract]   [Full Text] [Related]  

  • 11. Measuring availability, affordability and management of essential medicines in public hospitals of Burkina Faso.
    Saouadogo H
    World Hosp Health Serv; 2011; 47(1):8-11. PubMed ID: 21675631
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fatima Suleman: making medicines more widely available.
    Bull World Health Organ; 2017 Dec; 95(12):800-801. PubMed ID: 29200520
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of university technology transfer operations in assuring access to medicines and vaccines in developing countries.
    Nelsen L
    Yale J Health Policy Law Ethics; 2003; 3(2):301-8. PubMed ID: 14577146
    [No Abstract]   [Full Text] [Related]  

  • 14. The responsibility of research universities to promote access to essential medicines.
    't Hoen EF
    Yale J Health Policy Law Ethics; 2003; 3(2):293-300. PubMed ID: 14577145
    [No Abstract]   [Full Text] [Related]  

  • 15. Availability, price and affordability of asthma medicines in five Indian states.
    Kotwani A
    Int J Tuberc Lung Dis; 2009 May; 13(5):574-9. PubMed ID: 19383189
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oxymoron no more: the potential of nonprofit drug companies to deliver on the promise of medicines for the developing world.
    Hale VG; Woo K; Lipton HL
    Health Aff (Millwood); 2005; 24(4):1057-63. PubMed ID: 16012146
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ensuring access to essential medicines: some economic considerations.
    Maskus KE
    Spec Law Dig Health Care Law; 2003 Jul; (291):9-25. PubMed ID: 15206162
    [No Abstract]   [Full Text] [Related]  

  • 18. [Essential drugs: availability and prescription in Monastir (Tunisia) health district].
    Ben Salem K; Belghith Z; Ben Amor J; Harzallah S; Soltani MS
    East Mediterr Health J; 2000; 6(2-3):326-32. PubMed ID: 11556019
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Innovation and the WHO's essential medicines list: giving credit where credit is due.
    Wertheimer AI; Santella TM
    Res Social Adm Pharm; 2007 Mar; 3(1):137-44. PubMed ID: 17350562
    [No Abstract]   [Full Text] [Related]  

  • 20. Patently necessary: improving global access to essential medicines.
    CMAJ; 2003 Dec; 169(12):1257, 1259. PubMed ID: 14662658
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.